BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8400333)

  • 1. Idiopathic myelofibrosis--an update with particular reference to clinical aspects and prognosis.
    Hasselbalch HC
    Int J Clin Lab Res; 1993; 23(3):124-38. PubMed ID: 8400333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of interferon-alpha in the treatment of idiopathic myelofibrosis.
    Bachleitner-Hofmann T; Gisslinger H
    Ann Hematol; 1999 Dec; 78(12):533-8. PubMed ID: 10647876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic myelofibrosis: a clinical study of 80 patients.
    Hasselbalch H
    Am J Hematol; 1990 Aug; 34(4):291-300. PubMed ID: 2195869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Ann Hematol; 2001 Mar; 80(3):160-5. PubMed ID: 11320901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteomyelosclerosis with thalassemia trait: report of a rare association, study of platelet function tests and review of literature.
    Singh DK; Mahajan D; Nigam S; Singh T
    Hematology; 2008 Apr; 13(2):83-7. PubMed ID: 18616873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myelofibrosis with myeloid metaplasia: diagnosis and treatment].
    Dupriez B; Demory JL
    Rev Prat; 2005 Oct; 55(15):1680-5. PubMed ID: 16334205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in idiopathic myelofibrosis: a simple scoring system with prognostic significance.
    Hasselbalch H; Jensen BA
    Eur J Haematol; 1990 Mar; 44(3):172-8. PubMed ID: 2328790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelofibrosis revisited: characterization and classification of myelofibrosis in the setting of myeloproliferative disease.
    Gilbert HS
    Prog Clin Biol Res; 1984; 154():3-17. PubMed ID: 6382299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology and management of idiopathic myelofibrosis.
    Smith BD; Moliterno AR
    Curr Opin Oncol; 2001 Mar; 13(2):91-4. PubMed ID: 11224705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of bone marrow reticulin fibres in idiopathic myelofibrosis: evaluation of clinicopathological parameters in a scoring system.
    Iványi JL; Mahunka M; Papp A; Kiss A; Telek B
    Haematologia (Budap); 1994; 26(2):75-86. PubMed ID: 7890265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis.
    Hasselbalch H; Lisse I
    Eur J Haematol; 1991 May; 46(5):285-9. PubMed ID: 2044723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A
    Am J Hematol; 2011 Dec; 86(12):1017-26. PubMed ID: 22086865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic myelofibrosis: pathogenesis to treatment.
    Reilly JT
    Hematol Oncol; 2006 Jun; 24(2):56-63. PubMed ID: 16477581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic myelofibrosis.
    Barosi G; Hoffman R
    Semin Hematol; 2005 Oct; 42(4):248-58. PubMed ID: 16210038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival.
    Varki A; Lottenberg R; Griffith R; Reinhard E
    Medicine (Baltimore); 1983 Nov; 62(6):353-71. PubMed ID: 6633248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myeloproliferative disorders].
    Binder D; Fehr J
    Ther Umsch; 2004 Feb; 61(2):131-42. PubMed ID: 15018396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New insight into pathogenesis of idiopathic myelofibrosis--review].
    Xu ZQ; Sun XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1330-4. PubMed ID: 18088495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of myelofibrosis--where next?
    Qureshi M; Harrison C
    Expert Opin Pharmacother; 2011 Jul; 12(10):1453-5. PubMed ID: 21651445
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2013 Feb; 88(2):141-50. PubMed ID: 23349007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic myelofibrosis: pathogenesis, natural history and management.
    Reilly JT
    Blood Rev; 1997 Dec; 11(4):233-42. PubMed ID: 9481452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.